Characteristics | Value |
---|---|
Age (years) | |
Average | 71 |
Min to max | 57 to 86 |
Median | 72 |
Initial PSA level (ng/ml) | |
Average | 14.77 |
Min to max | 1.5 to 63 |
Median | 9.80 |
PSA level; at the time of the PET/CT request (ng/ml) | |
Average | 6.43 |
Min to max | 0.35 to 154 |
Median | 2.73 |
Gleason score | |
≤7 | 56 |
>7 | 4 |
NA | 5 |
TNM Stage | |
Any T2Nx | 2 |
Any T2N0M0 | 18 |
Any T2N1M0 | 1 |
Any T1c N0 or Nx | 15 |
Any T3N0M0 | 8 |
Any T3N1 | 5 |
Any T3Nx | 3 |
NA | 8 |
Initial treatment | |
Surg. Only | 9 |
Surg. A nd RT | 8 |
Surg. RT and HT | 2 |
RT only | 34 |
Brachytherapy only | 5 |
Time to double PSA (months) | |
>12 months | 6 |
= 12 months | 8 |
<12 months | 5 |
<6 months | 4 |
≤3 months | 5 |
NA | 32 |
Velocity (ng/ml/year) | |
Average | 2.87 |
Min to max | 0.05 to 15.45 |
Median | 2.03 |